RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $81 | +107.7% | 3,547 | +50.1% | 0.00% | – |
Q2 2023 | $39 | -7.1% | 2,363 | 0.0% | 0.00% | – |
Q1 2023 | $42 | -39.1% | 2,363 | 0.0% | 0.00% | – |
Q4 2022 | $69 | -99.9% | 2,363 | 0.0% | 0.00% | – |
Q3 2022 | $58,000 | +480.0% | 2,363 | 0.0% | 0.00% | – |
Q2 2022 | $10,000 | -65.5% | 2,363 | 0.0% | 0.00% | – |
Q1 2022 | $29,000 | +26.1% | 2,363 | 0.0% | 0.00% | – |
Q4 2021 | $23,000 | -25.8% | 2,363 | 0.0% | 0.00% | – |
Q3 2021 | $31,000 | -32.6% | 2,363 | 0.0% | 0.00% | – |
Q2 2021 | $46,000 | -8.0% | 2,363 | 0.0% | 0.00% | – |
Q1 2021 | $50,000 | -28.6% | 2,363 | 0.0% | 0.00% | – |
Q4 2020 | $70,000 | +37.3% | 2,363 | 0.0% | 0.00% | – |
Q3 2020 | $51,000 | -1.9% | 2,363 | 0.0% | 0.00% | – |
Q2 2020 | $52,000 | +44.4% | 2,363 | 0.0% | 0.00% | – |
Q1 2020 | $36,000 | -33.3% | 2,363 | 0.0% | 0.00% | – |
Q4 2019 | $54,000 | -5.3% | 2,363 | -9.5% | 0.00% | – |
Q2 2019 | $57,000 | -19.7% | 2,610 | 0.0% | 0.00% | – |
Q1 2019 | $71,000 | +4.4% | 2,610 | 0.0% | 0.00% | – |
Q4 2018 | $68,000 | – | 2,610 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |